Compound information
- Natural Products
- ZC1162214
- Molecular Formula
- C15H21NO4
- Molecular Weight
- 279.147058152 g/mol
- Structure
-
- IUPAC Name
- ethyl (2S)-2-(benzyloxycarbonylamino)-3-methyl-butanoate
- InChI
- InChI=1S/C15H21NO4/c1-4-19-14(17)13(11(2)3)16-15(18)20-10-12-8-6-5-7-9-12/h5-9,11,13H,4,10H2,1-3H3,(H,16,18)/t13-/m0/s1
- InChI Key
- KZBMEQVWSYFMNC-ZDUSSCGKSA-N
- SMILES
- CCOC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C
- Source
- ZINC000038227332
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 64.63 Å2 | LogP | 3.022 |
LogS | -3.081 | LogD | 2.91 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.128 | Pgp substrate | 0.001 |
HIA | 0.964 | F20 % | 0.99 |
F30 % | 0.758 | Caco-2 | -4.456 |
MDCK | -4.563 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.071 | PPB | 79.974 |
VD | 0.83 | Fu | 1.238 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.279 | CYP1A2 substrate | 0.707 |
CYP2A6 substrate | 0.525 | CYP2B6 substrate | 0.654 |
CYP2C19 inhibitor | 0.932 | CYP2C19 substrate | 0.944 |
CYP2C8 substrate | 0.837 | CYP2C9 inhibitor | 0.282 |
CYP2C9 substrate | 0.925 | CYP2D6 inhibitor | 0.021 |
CYP2D6 substrate | 0.566 | CYP2E1 substrate | 0.447 |
CYP3A4 inhibitor | 0.012 | CYP3A4 substrate | 0.944 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.739 | CL | 6.071 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.049 | Hepatotoxicity | 0.926 |
Mutagenicity | 0.034 | Rat Oral Acute Toxicity | 0.004 |
FDAMDD | 0.064 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.006 | Eye Corrosion | 0.004 |
Eye Irritation | 0.225 | Respiratory Toxicity | 0.006 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.862 | IGC50 | 3.164 |
LC50FM | 4.121 | LC50DM | 5.0 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.11 | NR-AR-LBD | 0.175 |
NR-AhR | 0.003 | NR-Aromatase | 0.046 |
NR-ER | 0.226 | NR-ER-LBD | 0.407 |
NR-PPAR-gamma | 0.194 | SR-ARE | 0.019 |
SR-ATAD5 | 0.352 | SR-HSE | 0.128 |
SR-MMP | 0.014 | SR-p53 | 0.019 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.